DLL1 and gastric cancer: This is consistent with the research conclusion of Giulia's18, Notch1 activity in gastric cancer is controlled by the epigenetic silencing of the ligand DLL1, and that Notch1 inhibition is associated with the diffuse type of gastric cancer.